Correlation between measures of insulin resistance in fasting and non-fasting blood

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Hancox, Robert J ^a   Landhuis, C Erik ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; INSULIN; LEPTIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MEASUREMENT; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 80052580719     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-23     Document Type: Article

References (15)

1. The assessment of insulin resistance in man. Wallace TM, Matthews DR, Diabet Med 2002 19 527 534 10.1046/j.1464-5491.2002.00745.x 12099954 (Pubitemid 35300672)
2. Diagnosing insulin resistance in the general population. McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, Temple LA, Duncan AW, Diabetes Care 2001 24 460 464 10.2337/diacare.24.3.460 11289468 (Pubitemid 32198413)
3. Relation of Direct and Surrogate Measures of Insulin Resistance to Cardiovascular Risk Factors in Nondiabetic Finnish Offspring of Type 2 Diabetic Individuals. Lorenzo C, Haffner SM, Stancakova A, Laakso M, J Clin Endocrinol Metab 2010 95 5082 5090 10.1210/jc.2010-1144 20702522
4. National Health and Nutrition Examination Survey. http://www.cdc.gov/ nchs/nhanes/nhanes2007-2008/FASTQX-E.htm
5. Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. Inoue M, Yano M, Yamakado M, Maehata E, Suzuki S, Metabolism 2006 55 1248 1254 10.1016/j.metabol.2006.05. 010 16919546 (Pubitemid 44215945)
6. Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals. Finucane FM, Luan J, Wareham NJ, Sharp SJ, O'Rahilly S, Balkau B, Flyvbjerg A, Walker M, Hojlund K, Nolan JJ, Savage DB, Diabetologia 2009 52 2345 2349 10.1007/s00125-009-1508-3 19756488
7. Biovariability of plasma adiponectin. Shand B, Elder P, Scott R, Frampton C, Willis J, Clin Chem Lab Med 2006 44 1264 1268 10.1515/CCLM.2006.227 17032140 (Pubitemid 44580810)
8. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? Brooks NL, Moore KS, Clark RD, Perfetti MT, Trent CM, Combs TP, Diabetes Obes Metab 2007 9 246 258 10.1111/j.1463-1326.2006.00596.x 17391150 (Pubitemid 46502042)
9. Leptin, adiponectin, and asthma: findings from a population-based cohort study. Sutherland TJ, Sears MR, McLachlan CR, Poulton R, Hancox RJ, Ann Allergy Asthma Immunol 2009 103 101 107 10.1016/S1081-1206(10)60161-5 19739421
10. Dunedin Multidisciplinary Health and Development Research Unit. http://dunedinstudy.otago.ac.nz/
11. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ, J Clin Endocrinol Metab 2000 85 2402 2410 10.1210/jc.85.7.2402 10902785 (Pubitemid 32269192)
12. HOMA Calculator. http://www.dtu.ox.ac.uk/homacalculator/index.php
13. Use and abuse of HOMA modeling. Wallace TM, Levy JC, Matthews DR, Diabetes Care 2004 27 1487 1495 10.2337/diacare.27.6.1487 15161807 (Pubitemid 38680001)
14. Adipokines and the clinical laboratory: what to measure, when and how? Hill MJ, Kumar S, McTernan PG, J Clin Pathol 2009 62 206 211 10.1136/jcp.2007.049171 19251951
15. Limitations in surrogate measures of insulin resistance. Buchanan TA, Watanabe RM, Xiang AH, J Clin Endocrinol Metab 2010 95 4874 4876 10.1210/jc.2010-2167 21051585